And on the seventh day, medicinal chemists created GRD
This article was originally published in Scrip
MedChemica’s Grand Rule Database lets companies share the fruits of hundreds of thousands of strands of medicinal chemistry wisdom without sharing compounds or proprietary rules. The more pharma companies join in, the more powerful GRD becomes. AstraZeneca and Roche were first: who’s next?
You may also be interested in...
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.
In a flat month, the market value of big pharma changed little overall. But the balance of power in immuno-oncology did shift significantly.